Longeveron Inc. Common Stock

LGVNNASDAQ • USD
ThemeLongevity & Aging›Age-Related Therapeutics
0.84 USD
↘ 0.01 (0.84%)AT CLOSE (11:59 AM EDT)
0.75
↘ 0.09 (10.24%)
POST MARKET (AS OF 07:59 PM EDT)
Post Market
AS OF 07:59 PM EDT
0.75
↘ 0.09 (10.24%)
🔴Market: CLOSED

LGVN is currently priced at $0.84. There is a divergence between signals — technical indicators rate "Strong Buy" but underlying fundamentals lean "Sell". Key drivers include a concerning Altman Z-Score in the distress zone, a weak Piotroski F-Score of 2/9, negative Return on Equity and a bullish Golden Cross on the moving averages. LGVN is fairly valued relative to its sector peers based on current multiples.

Technical & fundamental data as of Aug 24, 2026.

Open?$0.85
High?$0.87
Low?$0.80
Prev. Close?$0.84
Volume?939.6K
Avg. Volume?441.1K
VWAP?$0.84
Rel. Volume?2.13x
Bid / Ask
Bid?$0.74 × 200
Ask?$0.75 × 500
Spread?$0.01
Midpoint?$0.75
Valuation & Ratios
Market Cap?26.8M
Shares Out?30.4M
Float?27.7M
Float %?92.0%
P/E Ratio?N/A
P/B Ratio?2.57
EPS?-$0.74
Dividend?0.00%
Ex-Dividend?N/A
News
Profile
Longeveron Inc is a clinical stage biotechnology company developing regenerative medicines to address unmet medical needs. Its investigational product candidate is laromestrocel. Laromestrocel is a proprietary, scalable, allogeneic cellular therapy that has multiple potential modes of action that include pro-vascular, pro-regenerative, and anti-inflammatory mechanisms that collectively appear to promote tissue repair and healing. It is in clinical development of a single investigational product candidate, laromestrocel, for four potential indications: HLHS, Alzheimer's disease (AD), Pediatric Dilated Cardiomyopathy (pediatric DCM), and Aging-related Frailty. It operates in a single operating segment focused on developing regenerative medicines to address unmet medical needs.
Themes
Longevity & Aging›Age-Related TherapeuticsHealthcare - Genomics & Precision Medicine›Gene Therapy & Gene Editing
Employees
38
Market Cap
26.9M
Industry
PHARMACEUTICAL PREPARATIONS
Website
www.longeveron.com
Listed
2021-02-12
Address
1951 NW 7TH AVENUE
MIAMI, FL 33136
Phone: 305-302-7158
Technical OutlookStrong Buy
Strong SellNeutralStrong Buy
Long-Term (Tide)?▲ Bullish(+3/3)
Medium-Term (Wave)?▲ Bullish(+2/3)
Short-Term (Ripple)?– Neutral(0/3)
MA Alignment?Mixed
Full Technical Analysis →
Fundamental OutlookSell
Strong SellNeutralStrong Buy
F-Score?
12
Z-Score?
0
Momentum?
35
Short Sent.?
42
Piotroski F-Score?2/9Weak
Altman Z-Score?-14.26Distress
Confidence?60%Moderate
Full Fundamental Analysis →
Short InterestHigh
Short % of Float?5.60%Elevated
Short Interest?1.6M
Days to Cover?7.3
Free Float27.7M
Avg Daily Volume213.3K
Settlement Date2026-07-31
Financial Health
Current Ratio?2.23Strong
Quick Ratio?2.23Strong
Cash Ratio?1.98Strong
Debt/Equity?0.00Low
ValuationFAIRLY VALUEDvs 1 peers + S&P 500
Score
67/100
P/E?
N/A▾
P/B?
Peers
100
S&P
63
2.57CHEAP▾
P/S?
Peers
100
S&P
3
22.56HIGH▾
P/FCF?
N/A▾
EV/EBITDA?
S&P
97
-0.7CHEAP▾
EV/Sales?
Peers
100
S&P
3
14.07HIGH▾
Returns & Efficiency
ROE?
S&P
3
-225.7%WEAK▾
ROA?
S&P
3
-151.6%WEAK▾
Cash Flow & Enterprise
FCF?$-20534000
Enterprise Value?$16.7M
Fundamentals ratios updated end of day
MarketsMoversWatchlist